Usefulness of B-type natriuretic peptide in elderly patients with acute dyspnea.

Intensive Care Med

Department of Emergency Medicine and Surgery, Centre Hospitalo-Universitaire (CHU) Pitié-Salpêtrière Hospital, Assistance-Publique Hôpitaux de Paris (AP-HP), Université Pierre et Marie Curie, 75013 Paris, France.

Published: December 2004

AI Article Synopsis

  • The study aimed to differentiate cardiogenic pulmonary edema (CPE) from other causes of dyspnea in elderly patients over 65 years old using B-type natriuretic peptide (BNP) levels.
  • A total of 308 patients were analyzed, revealing that those with CPE had significantly higher median BNP levels compared to those without CPE, with a threshold of 250 pg/ml showing strong sensitivity and specificity.
  • The findings suggest that BNP measurement can enhance diagnostic accuracy for acute dyspnea in older adults, exceeding the accuracy of initial assessments by emergency physicians.

Article Abstract

Objective: Differentiating cardiogenic pulmonary edema (CPE) from respiratory causes of dyspnea is particularly difficult in elderly patients. The aim of our study was to evaluate B-type natriuretic peptide (BNP) in patients older than 65 years presenting with acute dyspnea.

Design: Prospective study.

Setting: Medical emergency department of a 2000-bed urban teaching hospital.

Patients: Patients aged over 65 years presenting with acute dyspnea and a respiratory rate more than 25/min or a PaO(2) below 70 mmHg, SpO(2 )less than 92%, PaCO(2) higher than 45 mmHg with pH less than 7.35, were included. BNP levels, measured blind at admission were compared with the final diagnosis (CPE or no CPE) as defined by experts.

Intervention: None.

Measurements And Results: Three hundred eight patients (mean age of 80 years) were enrolled in the study. The median BNP was 575 pg/ml [95% confidence interval (CI): 410-898] in the CPE group (n=141) versus 75 pg/ml (95% CI: 59-98) in the no CPE group (n=167) (p<0.001). The best threshold value of BNP was 250 pg/ml, with a sensitivity and specificity for CPE of 0.78 (95% CI: 0.71-0.84) and 0.90 (95% CI: 0.84-0.93), respectively. The area under the ROC curve was 0.874+/-0.081 (p<0.001). The accuracy of BNP-assisted diagnosis was higher than that of the emergency physician (0.84 versus 0.77, p<0.05).

Conclusion: Analysis of BNP is useful in elderly patients with acute dyspnea, but the threshold value is higher than that previously determined.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00134-004-2469-0DOI Listing

Publication Analysis

Top Keywords

b-type natriuretic
8
natriuretic peptide
8
elderly patients
8
acute dyspnea
8
years presenting
8
presenting acute
8
cpe group
8
patients
5
cpe
5
peptide elderly
4

Similar Publications

Background: Studies using machine learning to identify the target characteristics and develop predictive models for coronary artery disease severity in patients with premature myocardial infarction (PMI) are limited.

Methods: In this observational study, 1111 PMI patients (≤55 years) at Tianjin Chest Hospital from 2017 to 2022 were selected and divided according to their SYNTAX scores into a low-risk group (≤22) and medium-high-risk group (>22). These groups were further randomly assigned to a training or test set in a ratio of 7:3.

View Article and Find Full Text PDF

Purpose: The objective of this study was to explore the relationship among serum levels of the growth-stimulating expressed gene 2 protein (ST2), Galectin-3(GAL-3), N-terminal pro-B-type natriuretic peptide (NT-proBNP) in elderly hypertensive patients and heart failure with preserved ejection fraction (HFpEF).

Materials And Methods: Eighty-five elderly hypertensive patients with HFpEF were registered as the HFpEF group, and 46 hypertensive patients without HF were registered as the Non-HF group. The levels of serum sST2 (soluble ST2), Galectin-3, and NT-proBNP were measured, and related indexes of heart function were performed with echocardiography in two groups, respectively.

View Article and Find Full Text PDF

To develop a predictive model for improvement of ejection fraction 1 year after heart failure with reduced ejection fraction (HFrEF) following acute ST-segment elevation myocardial infarction (STEMI). This nested case-control study included STEMI patients diagnosed with HFrEF from a prospective multicenter multimodality imaging cohort between August 2014 and March 2021. Based on the improvement of left ventricular ejection fraction (LVEF) at baseline and 1-year follow-up, the patients were classified into the heart failure with improved ejection fraction (HFimpEF) group and the persistent HFrEF group.

View Article and Find Full Text PDF

A new simple chronic heart failure prognostic index based on five general parameters.

Int J Cardiol

January 2025

Internal Medicine Department, Centro Hospitalar e Universitário São João, Portugal; Department of Medicine, Faculty of Medicine of University of Porto, Portugal. Electronic address:

Background: Prognostic prediction in heart failure (HF) is challenging and no single marker has proven effective. We propose an index based on B-type natriuretic peptide (BNP) and four widely available parameters.

Methods: We retrospectively analyzed adult outpatients with chronic HF with systolic dysfunction followed from January 2012 to December 2020.

View Article and Find Full Text PDF

Background: Atrial fibrillation (AF) is the most prevalent arrhythmia encountered in clinical practice. Triglyceride glucose index (Tyg), a convenient evaluation variable for insulin resistance, has shown associations with adverse cardiovascular outcomes. However, studies on the Tyg index's predictive value for adverse prognosis in patients with AF without diabetes are lacking.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!